-
1
-
-
50549102861
-
Choice and interpretation of statistical tests used when competing risks are present
-
Dignam JJ, Kocherginsky MN: Choice and interpretation of statistical tests used when competing risks are present. J Clin Oncol 26:4027-4034, 2008
-
(2008)
J Clin Oncol
, vol.26
, pp. 4027-4034
-
-
Dignam, J.J.1
Kocherginsky, M.N.2
-
2
-
-
78049445066
-
Pitfalls of using composite primary end points in the presence of competing risks
-
Mell LK, Jeong JH: Pitfalls of using composite primary end points in the presence of competing risks. J Clin Oncol 28:4297-4299, 2010
-
(2010)
J Clin Oncol
, vol.28
, pp. 4297-4299
-
-
Mell, L.K.1
Jeong, J.H.2
-
3
-
-
73949129781
-
Predictors of competing mortality in advanced head and neck cancer
-
Mell LK, Dignam JJ, Salama JK, et al: Predictors of competing mortality in advanced head and neck cancer. J Clin Oncol 28:15-20, 2010
-
(2010)
J Clin Oncol
, vol.28
, pp. 15-20
-
-
Mell, L.K.1
Dignam, J.J.2
Salama, J.K.3
-
4
-
-
80052981071
-
Populationbased study of competing mortality in head and neck cancer
-
Rose BS, Jeong JH, Nath SK, et al: Populationbased study of competing mortality in head and neck cancer. J Clin Oncol 29:3503-3509, 2011
-
(2011)
J Clin Oncol
, vol.29
, pp. 3503-3509
-
-
Rose, B.S.1
Jeong, J.H.2
Nath, S.K.3
-
5
-
-
36348959692
-
More on cetuximab in head and neck cancer
-
author reply 2202-2203
-
Mell LK, Weichselbaum RR: More on cetuximab in head and neck cancer. N Engl J Med 357: 2201-2202, 2007; author reply 2202-2203
-
(2007)
N Engl J Med
, vol.357
, pp. 2201-2202
-
-
Mell, L.K.1
Weichselbaum, R.R.2
-
6
-
-
1642382955
-
Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy
-
Argiris A, Brockstein BE, Haraf DJ, et al: Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy. Clin Cancer Res 10:1956-1962, 2004
-
(2004)
Clin Cancer Res
, vol.10
, pp. 1956-1962
-
-
Argiris, A.1
Brockstein, B.E.2
Haraf, D.J.3
-
7
-
-
84869385274
-
Predictors of competing mortality to invasive breast cancer incidence in the Canadian National Breast Screening study
-
Taghipour S, Banjevic D, Fernandes J, et al: Predictors of competing mortality to invasive breast cancer incidence in the Canadian National Breast Screening study. BMC Cancer 12:299, 2012
-
(2012)
BMC Cancer
, vol.12
, pp. 299
-
-
Taghipour, S.1
Banjevic, D.2
Fernandes, J.3
-
8
-
-
84903120366
-
Validated competing event model for the stage I-II endometrial cancer population
-
Carmona R, Gulaya S, Murphy JD, et al: Validated competing event model for the stage I-II endometrial cancer population. Int J Radiat Oncol Biol Phys 89:888-898, 2014
-
(2014)
Int J Radiat Oncol Biol Phys
, vol.89
, pp. 888-898
-
-
Carmona, R.1
Gulaya, S.2
Murphy, J.D.3
-
11
-
-
1542532754
-
A proportional hazards model for the subdistribution of a competing risk
-
Fine JP, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496-509, 1999
-
(1999)
J Am Stat Assoc
, vol.94
, pp. 496-509
-
-
Fine, J.P.1
Gray, R.J.2
-
12
-
-
33846855572
-
Cumulative incidence in competing risks data and competing risks regression analysis
-
Kim HT: Cumulative incidence in competing risks data and competing risks regression analysis. Clin Cancer Res 13:559-565, 2007
-
(2007)
Clin Cancer Res
, vol.13
, pp. 559-565
-
-
Kim, H.T.1
-
13
-
-
84859842971
-
The use and interpretation of competing risks regression models
-
Dignam JJ, Zhang Q, Kocherginsky M: The use and interpretation of competing risks regression models. Clin Cancer Res 18:2301-2308, 2012
-
(2012)
Clin Cancer Res
, vol.18
, pp. 2301-2308
-
-
Dignam, J.J.1
Zhang, Q.2
Kocherginsky, M.3
-
14
-
-
0034531923
-
Development of a comorbidity index using physician claims data
-
Klabunde CN, Potosky AL, Legler JM, et al: Development of a comorbidity index using physician claims data. J Clin Epidemiol 53:1258-1267, 2000
-
(2000)
J Clin Epidemiol
, vol.53
, pp. 1258-1267
-
-
Klabunde, C.N.1
Potosky, A.L.2
Legler, J.M.3
-
15
-
-
0026562206
-
Applications of crude incidence curves
-
Korn EL, Dorey FJ: Applications of crude incidence curves. Stat Med 11:813-829, 1992
-
(1992)
Stat Med
, vol.11
, pp. 813-829
-
-
Korn, E.L.1
Dorey, F.J.2
-
16
-
-
21144484803
-
On the use of cause-specific failure and conditional failure probabilities: Examples from clinical oncology data
-
Gaynor JJ, Feuer EJ, Tan CC, et al: On the use of cause-specific failure and conditional failure probabilities: Examples from clinical oncology data. J Am Stat Assoc 88:400-409, 1993
-
(1993)
J Am Stat Assoc
, vol.88
, pp. 400-409
-
-
Gaynor, J.J.1
Feuer, E.J.2
Tan, C.C.3
-
17
-
-
78650039392
-
Time-dependent predictive accuracy in the presence of competing risks
-
Saha P, Heagerty PJ: Time-dependent predictive accuracy in the presence of competing risks. Biometrics 66:999-1011, 2010
-
(2010)
Biometrics
, vol.66
, pp. 999-1011
-
-
Saha, P.1
Heagerty, P.J.2
-
18
-
-
34548575455
-
Limitations of applying summary results of clinical trials to individual patients: The need for risk stratification
-
Kent DM, Hayward RA: Limitations of applying summary results of clinical trials to individual patients: The need for risk stratification. JAMA 298:1209-1212, 2007
-
(2007)
JAMA
, vol.298
, pp. 1209-1212
-
-
Kent, D.M.1
Hayward, R.A.2
-
19
-
-
84930754128
-
Competing events and costs of clinical trials: Analysis of a randomized trial in prostate cancer
-
Zakeri K, Rose BS, D'Amico AV, et al: Competing events and costs of clinical trials: Analysis of a randomized trial in prostate cancer. Radiother Oncol 115:114-119, 2015
-
(2015)
Radiother Oncol
, vol.115
, pp. 114-119
-
-
Zakeri, K.1
Rose, B.S.2
D'Amico, A.V.3
-
20
-
-
84884908099
-
Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and earlystage prostate cancer
-
Daskivich TJ, Chamie K, Kwan L, et al: Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and earlystage prostate cancer. Cancer 119:3446-3453, 2013
-
(2013)
Cancer
, vol.119
, pp. 3446-3453
-
-
Daskivich, T.J.1
Chamie, K.2
Kwan, L.3
-
21
-
-
67449110637
-
Survivorship beyond convalescence: 48-Month quality-of-life outcomes after treatment for localized prostate cancer
-
Gore JL, Kwan L, Lee SP, et al: Survivorship beyond convalescence: 48-Month quality-of-life outcomes after treatment for localized prostate cancer. J Natl Cancer Inst 101:888-892, 2009
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 888-892
-
-
Gore, J.L.1
Kwan, L.2
Lee, S.P.3
-
22
-
-
0034685027
-
Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study
-
Stanford JL, Feng Z, Hamilton AS, et al: Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study. JAMA 283:354-360, 2000
-
(2000)
JAMA
, vol.283
, pp. 354-360
-
-
Stanford, J.L.1
Feng, Z.2
Hamilton, A.S.3
-
23
-
-
84878059899
-
Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. Population-based cohort of men with prostate cancer
-
Daskivich TJ, Fan KH, Koyama T, et al: Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer. Ann Intern Med 158:709-717, 2013
-
(2013)
Ann Intern Med
, vol.158
, pp. 709-717
-
-
Daskivich, T.J.1
Fan, K.H.2
Koyama, T.3
-
24
-
-
79955705831
-
Radical prostatectomy versus watchful waiting in early prostate cancer
-
SPCG-4 Investigators
-
Bill-Axelson A, Holmberg L, Ruutu M, et al; SPCG-4 Investigators: Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 364:1708-1717, 2011
-
(2011)
N Engl J Med
, vol.364
, pp. 1708-1717
-
-
Bill-Axelson, A.1
Holmberg, L.2
Ruutu, M.3
-
25
-
-
79955495412
-
Overtreatment of men with low-risk prostate cancer and significant comorbidity
-
Daskivich TJ, Chamie K, Kwan L, et al: Overtreatment of men with low-risk prostate cancer and significant comorbidity. Cancer 117:2058-2066, 2011
-
(2011)
Cancer
, vol.117
, pp. 2058-2066
-
-
Daskivich, T.J.1
Chamie, K.2
Kwan, L.3
-
26
-
-
77952787905
-
Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients
-
Datema FR, Ferrier MB, Van Der Schroeff MP, et al: Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients. Head Neck 32:728-736, 2010
-
(2010)
Head Neck
, vol.32
, pp. 728-736
-
-
Datema, F.R.1
Ferrier, M.B.2
Van Der Schroeff, M.P.3
-
27
-
-
84903897547
-
Noncancer health events as a leading cause of competing mortality in advanced head and neck cancer
-
Kwon M, Roh JL, Song J, et al: Noncancer health events as a leading cause of competing mortality in advanced head and neck cancer. AnnOncol 25: 1208-1214, 2014
-
(2014)
AnnOncol
, vol.25
, pp. 1208-1214
-
-
Kwon, M.1
Roh, J.L.2
Song, J.3
-
28
-
-
77955450647
-
Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy
-
(Phila)
-
Yi M, Hunt KK, Arun BK, et al: Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer Prev Res (Phila) 3:1026-1034, 2010
-
(2010)
Cancer Prev Res
, vol.3
, pp. 1026-1034
-
-
Yi, M.1
Hunt, K.K.2
Arun, B.K.3
-
29
-
-
78649614779
-
Predictors of competing mortality in early breast cancer
-
Mell LK, Jeong JH, Nichols MA, et al: Predictors of competing mortality in early breast cancer. Cancer 116:5365-5373, 2010
-
(2010)
Cancer
, vol.116
, pp. 5365-5373
-
-
Mell, L.K.1
Jeong, J.H.2
Nichols, M.A.3
-
32
-
-
2442696436
-
Prognostic importance of comorbidity in a hospitalbased cancer registry
-
Piccirillo JF, Tierney RM, Costas I, et al: Prognostic importance of comorbidity in a hospitalbased cancer registry. JAMA 291:2441-2447, 2004
-
(2004)
JAMA
, vol.291
, pp. 2441-2447
-
-
Piccirillo, J.F.1
Tierney, R.M.2
Costas, I.3
-
34
-
-
77954775138
-
Should cause of death from the death certificate be used to examine cancer-specific survival? A study of patients with distant stage disease
-
Lund JL, Harlan LC, Yabroff KR, et al: Should cause of death from the death certificate be used to examine cancer-specific survival? A study of patients with distant stage disease. Cancer Invest 28: 758-764, 2010
-
(2010)
Cancer Invest
, vol.28
, pp. 758-764
-
-
Lund, J.L.1
Harlan, L.C.2
Yabroff, K.R.3
-
35
-
-
84929941498
-
Smoking and mortality-Beyond established causes
-
Carter BD, Abnet CC, Feskanich D, et al: Smoking and mortality-Beyond established causes. N Engl J Med 372:631-640, 2015
-
(2015)
N Engl J Med
, vol.372
, pp. 631-640
-
-
Carter, B.D.1
Abnet, C.C.2
Feskanich, D.3
-
36
-
-
77954190940
-
Human papillomavirus and survival of patients with oropharyngeal cancer
-
Ang KK, Harris J, Wheeler R, et al: Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24-35, 2010
-
(2010)
N Engl J Med
, vol.363
, pp. 24-35
-
-
Ang, K.K.1
Harris, J.2
Wheeler, R.3
-
37
-
-
84923197605
-
Comprehensive genomic characterization of head and neck squamous cell carcinomas
-
Cancer Genome Atlas Network: Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517:576-582, 2015
-
(2015)
Nature
, vol.517
, pp. 576-582
-
-
-
38
-
-
84922592521
-
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: A retrospective cohort study
-
Lalonde E, Ishkanian AS, Sykes J, et al: Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: A retrospective cohort study. Lancet Oncol 15:1521-1532, 2014
-
(2014)
Lancet Oncol
, vol.15
, pp. 1521-1532
-
-
Lalonde, E.1
Ishkanian, A.S.2
Sykes, J.3
-
39
-
-
0343918505
-
BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer
-
Couch FJ, DeShano ML, Blackwood MA, et al: BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336: 1409-1415, 1997
-
(1997)
N Engl J Med
, vol.336
, pp. 1409-1415
-
-
Couch, F.J.1
DeShano, M.L.2
Blackwood, M.A.3
-
41
-
-
84859817083
-
Risk models and patientcentered evidence: Should physicians expect one right answer?
-
Kent DM, Shah ND: Risk models and patientcentered evidence: Should physicians expect one right answer? JAMA 307:1585-1586, 2012
-
(2012)
JAMA
, vol.307
, pp. 1585-1586
-
-
Kent, D.M.1
Shah, N.D.2
-
42
-
-
84911448670
-
Population and personalized medicine in the modern era
-
Mega JL, Sabatine MS, Antman EM: Population and personalized medicine in the modern era. JAMA 312:1969-1970, 2014
-
(2014)
JAMA
, vol.312
, pp. 1969-1970
-
-
Mega, J.L.1
Sabatine, M.S.2
Antman, E.M.3
|